LAURIE SCHLUTER: Open Payments
NPI 1922030485 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 14 payments from 8 companies in 2025. Trend: 2023 $793 · 2024 $743 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $204 |
| Organon LLC | 1 | $138 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| KYOWA KIRIN, INC. | 1 | $121 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $112 |
| GENZYME CORPORATION | 1 | $110 |
| Neurelis, Inc. | 1 | $30 |
| UCB, Inc. | 1 | $26 |
Products named: VTAMA, WAINUA, QULIPTA, DUPIXENT, UBRELVY, VALTOCO, Briviact, BOTOX.
Industry payments across LA — which companies pay providers there.
